CE / CME
Explore the molecular pharmacology of VMAT2 inhibitors, comparing agents, including their pharmacokinetic profiles, receptor selectivity, and extended-release formulations designed for dysphagia management. Analyze age-related metabolic changes impacting drug clearance, and titration protocols for patients with hepatic impairment or polypharmacy, emphasizing fall risk reduction and swallow-safe administration.
Social Workers: 1.00 ASWB ACE CE Credit
Nurse Practitioners/Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit
Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit
Pharmacists: 1.00 contact hour (0.1 CEUs)
Psychologists: 1.00 APA CE Credit
Physicians: maximum of 1.00 AMA PRA Category 1 Credit™
Released: December 30, 2025
Expiration: December 29, 2026
Share
Provided by Clinical Care Options, LLC dba Decera Clinical Education
Supported by an educational grant from Neurocrine Biosciences.
Neurocrine Biosciences
This educational activity is intended for psychiatrists, geriatricians, nurse practitioners, physician associates, general and family practice physicians, pharmacists, psychologists, social workers, and other healthcare professionals who treat patients or advise HCP care teams regarding their patients with tardive dyskinesia who may benefit from this education.
The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with tardive dyskinesia.
Upon completion of this activity, participants should be able to:
Identify risk factors for TD that increase susceptibility in older individuals
Implement best practices for using screening and assessment tools with patients at risk for TD
Interpret screening tool results to identify TD, considering patient and caregiver reports
Evaluate the safety, effectiveness, and pharmacologic properties of VMAT2 inhibitors for managing TD in older adults and special populations
Develop an individualized treatment plan for diverse patient populations with TD
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Primary AuthorSanjay Gupta, MD: consultant/advisor/speaker: AbbVie, Alkermes, Bristol Myers Squibb, Intra-Cellular, Johnson & Johnson, Neurocrine, Otsuka, Teva, Vanda.
The planners and content peer reviewers from Decera Clinical Education do not have any relevant financial relationships to disclose, except Michael Asbach, DMSc, PA-C, as noted below:
Michael Asbach, DMSc, PA-C: consultant/advisor/speaker: AbbVie, Axsome Therapeutics, Bristol Myers Squibb, Johnson & Johnson, Intra-Cellular, Neurocrine Biosciences, Otsuka, Sage/Biogen, Teva.
Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 30, 2025, through December 29, 2026:
Login or Sign Up for an account by clicking at the top of this page.
Read the target audience, learning objectives, and faculty disclosures.
View and study the content in its entirety.
Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Clinical Care Options, LLC dba Decera Clinical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour, including 1 hour of pharmacotherapy credit.
Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-504-H01-P
Type of Activity: Application
Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until December 29, 2026. PAs should only claim credit commensurate with the extent of their participation.
Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
This activity offers 1 continuing education credit for psychologists.
Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC dba Decera Clinical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1 clinical continuing education credit.
ABMS Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, VMAT2 Inhibitors in Geriatric and Complex Populations: Mechanistic Insights, Formulation Advances, and Age-Appropriate Dosing Strategies, has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.